July 6, 2020 / 3:12 PM / a month ago

BRIEF-J&J Says Will Make Bedaquiline Available To Stop TB Partnership’s Global Drug Facility At $340 Per Six-Month Treatment Course

July 6 (Reuters) - Johnson & Johnson:

* J&J - EFFECTIVE IMMEDIATELY, CO WILL MAKE BEDAQUILINE AVAILABLE TO STOP TB PARTNERSHIP’S GLOBAL DRUG FACILITY AT $340 PER SIX-MONTH TREATMENT COURSE

* J&J - THE STOP TB PARTNERSHIP EXPECTS TO RECEIVE CONFIRMED ORDERS FOR AT LEAST 125,000 PEOPLE WITH DR-TB IN 2020

* J&J - STOP TB PARTNERSHIP, CO ANNOUNCE PRICE REDUCTION FOR BEDAQUILINE FOR DRUG-RESISTANT TUBERCULOSIS TREATMENT IN LOW-& MIDDLE-INCOME COUNTRIES Source text: (bit.ly/2VQNarP) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below